Welcome to our dedicated page for PSYC CORPORATION news (Ticker: PSYC), a resource for investors and traders seeking the latest updates and insights on PSYC CORPORATION stock.
PSYC Corporation, traded under the symbol PSYC in the OTC Pink Market, is a leading player in the mental health and wellness industry. The company focuses on innovative solutions and technologies to address mental health issues, offering a range of products and services. With a strong emphasis on research and development, PSYC Corporation is committed to improving the quality of mental healthcare globally.
PSYC Corporation (OTCPink: PSYC), a media leader in the medicinal psychedelics sector, has announced the incorporation of Spotlight Media Corporation as a wholly owned subsidiary. This move is aimed at enhancing the Company's media ventures within and outside the psychedelics industry. Since launching Psychedelic Spotlight in 2020, PSYC has become a prominent content producer. CEO David Flores emphasized the goal to create interconnected media assets and diversify revenue streams, potentially generating increased value for shareholders.
PSYC Corporation, formerly Global Trac Solutions, Inc., has officially changed its name to better represent its evolution into a leader in the medicinal psychedelics media sector. The company continues to trade under the ticker symbol PSYC. CEO David Flores emphasized the transformation and commitment to creating long-term shareholder value through its Psychedelic Spotlight platform. As part of the rebranding, PSYC has launched a new corporate website and aims to diversify revenue streams within the emerging psychedelic market, which is poised for significant growth.
Global Trac Solutions (OTCPink: PSYC) announces completion of an all-stock acquisition agreement for The Psychedelic Investor from Illuminer Services. This acquisition includes access to over 100 videos focused on the psychedelic business sector. Co-founders James Hallifax and Maria Holyanova join PSYC as Content Director and Director of Psychedelic Spotlight, respectively. The partnership aims to enhance PSYC’s multimedia platform, leveraging their expertise to foster growth and increase audience engagement within the medicinal psychedelics industry.
Global Trac Solutions, Inc. (OTCPink: PSYC) will host its inaugural CEO Roundtable on February 15, 2022, at 9:30 am EST via live stream on YouTube. This event, moderated by James Hallifax from Psychedelic Spotlight, will feature CEOs from leading companies in the medicinal psychedelic space, including Cybin Corp., MindMed, and Field Trip Health. Discussions will focus on the current state and future potential of the medicinal psychedelic industry. PSYC aims to enhance its authority and visibility within this growing sector through this initiative.
Global Trac Solutions (OTCPink: PSYC) announced record-breaking traffic for its platform, Psychedelic Spotlight, with over 650K page views and 1M impressions in January. This growth reflects increased public interest in psychedelics as a treatment for mental health, with the market projected to exceed $10B by 2027. The company aims to establish itself as a leading resource in this sector by attracting industry experts and leveraging its media capabilities. CEO David Flores emphasized the importance of community feedback and industry positioning for long-term shareholder value.
Global Trac Solutions (OTCPink: PSYC) provided a business update regarding its investment in The Conscious Fund (TCF). In January 2021, PSYC invested $125,000 in TCF, aiming to diversify within the medicinal psychedelics market. The company expressed optimism about TCF's portfolio, noting significant advancements in companies like Albert Labs, Wesana Health, Enveric Biosciences, Cybin, and Numinus Wellness. CEO David Flores highlighted the potential for increased shareholder value from this investment, despite the inherent uncertainties in such ventures.
Global Trac Solutions (OTCPink: PSYC) announces a licensing agreement with Ronin Content Service to host video content from its platform, Psychedelic Spotlight, on the ALTRD.TV network. This media partnership aims to enhance visibility and audience engagement for Psychedelic Spotlight, launching the series "Spotlight in Focus" in early February. The collaboration is anticipated to boost monetization efforts and establish Psychedelic Spotlight as a significant player in the psychedelics media landscape.
Global Trac Solutions (OTCPink: PSYC) announced it has become a 50% equity stakeholder in PsycheDev, a digital mental wellness platform, through its partnership with Digital Acorn Ltd.. This collaboration aims to co-develop the PsycheDev app, initially designed for the medicinal psychedelics community. Following a previous acquisition of the app's concept, PSYC intends to leverage its experience to optimize monetization strategies. The app is projected to align with successful models in the mental wellness space, drawing inspiration from apps like Calm, which reported $23M in revenue in Q1 2021.
Global Trac Solutions (OTCPink: PSYC) has partnered with MediaTek, LLC, an investor relations firm, to enhance brand awareness and community engagement in the medicinal psychedelics sector. This collaboration aims to fortify PSYC's corporate identity and improve communication with public markets and shareholders. CEO David Flores expressed optimism about the partnership, highlighting the potential growth in the psychedelics industry. PSYC will also host a live Q&A session on January 26, 2022, to engage with shareholders.
Global Trac Solutions (OTCPink: PSYC) announced that its Psychedelic Spotlight media platform achieved nearly 620K page views in December 2021, marking three consecutive months over 500K views. The company launched a revamped platform to enhance user experience with faster loads and improved interfaces. CEO David Flores highlighted the site's role in monetization and plans to focus on content expansion. Media Director Swati Sharma noted a shift from investment-focused content to broader cultural news, contributing to site growth. PSYC aims to lead in the medicinal psychedelic space.
FAQ
What is the current stock price of PSYC CORPORATION (PSYC)?
What is the market cap of PSYC CORPORATION (PSYC)?
What is the primary focus of PSYC Corporation?
In which market is PSYC Corporation traded?
What sets PSYC Corporation apart in the mental health industry?
How does PSYC Corporation contribute to improving mental healthcare globally?
What is the contact information for PSYC Corporation?
What is the vision of PSYC Corporation?
What are some of the recent achievements of PSYC Corporation?
How does PSYC Corporation stay ahead in the industry?
What can investors expect from PSYC Corporation?
How does PSYC Corporation address mental health challenges?
